Entrak Soothe Eye Ointment contains Tacrolimus 0.03% w/w, a potent immunomodulatory agent indicated for the treatment of inflammatory ocular conditions such as atopic keratoconjunctivitis and vernal keratoconjunctivitis. Tacrolimus acts by inhibiting calcineurin, thereby suppressing T-lymphocyte activation and reducing the release of pro-inflammatory cytokines, which helps alleviate ocular inflammation and associated symptoms including redness, itching, and swelling. Entrak Soothe Eye Ointment is specifically formulated for topical ophthalmic use, providing targeted therapeutic effects with minimal systemic absorption. It is typically prescribed for patients who have shown inadequate response or intolerance to conventional corticosteroid therapy, offering an alternative with a lower risk of steroid-induced side effects such as elevated intraocular pressure or cataract formation. The ointment should be applied as directed by a healthcare professional, usually twice daily, with careful attention to hygiene to prevent contamination. Patients should avoid contact with contact lenses during treatment and report any adverse reactions such as burning, stinging, or visual disturbances promptly. Entrak Soothe Eye Ointment is contraindicated in patients with hypersensitivity to tacrolimus or any component of the formulation. Regular ophthalmologic monitoring is recommended to assess therapeutic response and detect potential adverse effects.